ITF2357 regulates NF‐κB signaling pathway to protect barrier integrity in retinal pigment epithelial cells
The FASEB Journal · 2024
DOI: 10.1096/fj.202301592r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Rayne R Lim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin Eye Institute, Milwaukee, Wisco…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Macular Edema, Hydroxamic Acids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCRR NIH HHS, NEI NIH HHS, National Eye Institute.
Abstract (Originalsprache)
The robust integrity of the retinal pigment epithelium (RPE), which contributes to the outer brain retina barrier (oBRB), is compromised in several retinal degenerative and vascular disorders, including diabetic macular edema (DME). This study evaluates the role of a new generation of histone deacetylase inhibitor (HDACi), ITF2357, in regulating outer blood‐retinal barrier function and investigates the underlying mechanism of action in inhibiting TNFα‐induced damage to RPE integrity. Using the immortalized RPE cell line (ARPE‐19), ITF2357 was found to be non‐toxic between 50 nM and 5 μM concentrations. When applied as a pre‐treatment in conjunction with an inflammatory cytokine, TNFα, the HDACi was safe and effective in preventing epithelial permeability by fortifying tight junction (ZO‐1, ‐2, ‐3, occludin, claudin‐1, ‐2, ‐3, ‐5, ‐19) and adherens junction (E‐cadherin, Nectin‐1) protein expression post‐TNFα stress. Mechanistically, ITF2357 depicted a late action at 24 h via attenuating IKK, IκBα, and p65 phosphorylation and ameliorated the expression of IL‐1β, IL‐6, and MCP‐1. Also, ITF2357 delayed IκBα synthesis and turnover. The use of Bay 11‐7082 and MG132 further uncovered a possible role for ITF2357 in non‐canonical NF‐κB activation. Overall, this study revealed the protection effects of ITF2357 by regulating the turnover of tight and adherens junction proteins and modulating NF‐κB signaling pathway in the presence of an inflammatory stressor, making it a potential therapeutic application for retinal vascular diseases such as DME with compromised outer blood‐retinal barrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin Eye Institute, Milwaukee, Wisconsin, USA.
- Singapore Eye Research Institute, Singapore, Singapore.
- Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Epithelial Polarity in Disease & Tissue Regeneration Laboratory, Institute of Molecular and Cellular Biology, A*STAR Agency, Singapore, Singapore.
- Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
ORCID-Profile: Shyam S Chaurasia
Förderung
- NCRR NIH HHS
- NEI NIH HHS
- National Eye Institute
Zitieren
APA
Lim, R. R., Mahaling, B., Tan, A., Mehta, M., Kaur, C., Hunziker, W., Kim, J. E., Barathi, V. A., Ghosh, A., & Chaurasia, S. S. (2024). ITF2357 regulates NF‐κB signaling pathway to protect barrier integrity in retinal pigment epithelial cells. The FASEB Journal. https://doi.org/10.1096/fj.202301592r
Vancouver
Lim RR, Mahaling B, Tan A, Mehta M, Kaur C, Hunziker W, et al. ITF2357 regulates NF‐κB signaling pathway to protect barrier integrity in retinal pigment epithelial cells. The FASEB Journal. 2024. doi:10.1096/fj.202301592r
BibTeX
@article{Lim2024,
author = {Lim, Rayne R and Mahaling, Binapani and Tan, Alison and Mehta, Milan and Kaur, Charanjit and Hunziker, Walter and Kim, Judy E and Barathi, Veluchamy A and Ghosh, Arkasubhra and Chaurasia, Shyam S},
title = {ITF2357 regulates NF‐κB signaling pathway to protect barrier integrity in retinal pigment epithelial cells},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202301592r}
}
EUVIMED